Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
The American Journal of Medicine|December 6, 2006
Bupropion for smokers hospitalized with acute cardiovascular diseaseNancy A Rigotti, Anne N Thorndike, Susan Regan, et al.
Journal of the American College of Cardiology|March 1, 1987
Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon cathetersJ D Alderman, G I Gabliani, C H McCabe, et al.
Journal of the American College of Cardiology|September 11, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Circulation|July 14, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Circulation|October 1, 1986
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansionR G McKay, M A Pfeffer, R C Pasternak, et al.
Circulation|March 17, 2005
Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN)Kim Sutton-Tyrrell, Rachel P Wildman, Karen A Matthews, et al.
The American Journal of Cardiology|February 1, 1987
Usefulness of percutaneous transluminal coronary angioplasty for unstable angina pectoris after non-Q-wave acute myocardial infarctionR D Safian, L D Snyder, B A Synder, et al.
The American Journal of Cardiology|August 16, 2005
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendationsMichael H Davidson, Kevin C Maki, Thomas A Pearson, et al.
International Journal of Clinical Practice|January 27, 2009
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemiaD Maccubbin, H E Bays, A G Olsson, et al.
Pageof 16